ERBB2 and cancer: For instance, in human epidermal growth factor receptor 2 (HER2) positive breast cancers, the Linc00969 lncRNA has been found to promote resistance to trastuzumab, a monoclonal antibody that targets HER2 expressed in cancer cells.